연구성과로 돌아가기
2022 연구자 정보 (142 / 1074)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kwon, Song (Kwon, S) |
Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon 21999, South Korea |
|
|
[JCR상위 5.9] Greater Plasma Protein Adsorption on Mesoporous Silica Nanoparticles Aggravates Atopic Dermatitis | SCIE | 5.9 | NANOSCIENCE & NANOTECHNOLOGY;PHARMACOLOGY & PHARMACY | dkhang@gachon.ac.kr;shkim72@knu.ac.kr; | ||
|
Lee, Chang-Hyeong (Lee, CH) |
Daegu Catholic Univ, Sch Med, Internal Med, Gyongsan, South Korea |
|
|
[JCR상위 5.9] NONINVASIVE PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C: A MULTICENTER STUDY | SCIE | 5.9 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Lee, Hye-Jeong (Lee, HJ) |
Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea Yonsei Univ, Severance Hosp, Res Inst Radiol Sci, Coll Med, Seoul, South Korea |
|
0000-0003-4349-9174 Lee, Hye-Jeong |
[JCR상위 5.9] Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement | SCIE | 5.9 | PATHOLOGY | shimhs@yuhs.ac; | ||
|
Lee, Jae Chang (Lee, JC) |
제1저자 | Yeungnam Univ, Coll Med, Internal Med, Gyongsan, South Korea |
|
|
[JCR상위 5.9] IMPACT OF SARCOPENIA AND ADVANCED FIBROSIS ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE | SCIE | 5.9 | GASTROENTEROLOGY & HEPATOLOGY | ||
|
Lee, Jin Gu (Lee, JG) |
Yonsei Univ, Severance Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea |
W-5616-2018 Lee, Jae |
|
[JCR상위 5.9] Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement | SCIE | 5.9 | PATHOLOGY | shimhs@yuhs.ac; | ||
|
Lee, Myong-In (Lee, MI) |
Ulsan Natl Inst Sci & Technol, Dept Urban & Environm Engn, Ulsan, South Korea |
F-3578-2010 Lee, Myong-In |
|
[JCR상위 5.9] Development of model output statistics based on the least absolute shrinkage and selection operator regression for forecasting next-day maximum temperature in South Korea | SCIE | 5.9 | METEOROLOGY & ATMOSPHERIC SCIENCES | dhcha@unist.ac.kr; | ||
|
Lee, Tae Han (Lee, TH) |
Kyungpook Natl Univ, Sch Med, Daegu, South Korea |
|
|
[JCR상위 5.9] NONINVASIVE PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C: A MULTICENTER STUDY | SCIE | 5.9 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Lin, Chuan-Hao (Lin, CH) |
Childrens Hosp Los Angeles, Los Angeles, CA USA Univ Southern Calif, Los Angeles, CA USA Childrens Hosp Los Angeles, Div Gastroenterol Hepatol & Nutr, Los Angeles, CA 90027 USA |
AAH-6563-2019 Lin, Chuan-Hao |
|
[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF) [JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B |
SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | frida.abramov@gilead.com; | ||
|
Liu, Yang (Liu, Y) |
Gilead Sci Inc, Foster City, CA USA Gilead Sci Inc, Clin Virol, Foster City, CA USA |
|
|
[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF) [JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B |
SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | frida.abramov@gilead.com; | ||
|
Makowsky, Mallory (Makowsky, M) |
Astrazeneca, Gaithersburg, MD USA |
|
|
[JCR상위 5.9] OUTCOMES BY BASELINE LIVER FUNCTION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH TREMELIMUMAB AND DURVALUMAB IN THE PHASE 3 HIMALAYA STUDY | SCIE | 5.9 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Marcovitz, Michelle (Marcovitz, M) |
Astrazeneca, Gaithersburg, MD USA |
|
|
[JCR상위 5.9] OUTCOMES BY BASELINE LIVER FUNCTION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH TREMELIMUMAB AND DURVALUMAB IN THE PHASE 3 HIMALAYA STUDY | SCIE | 5.9 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Masi, Gianluca (Masi, G) |
Pisa Univ, Pisa, Italy |
|
|
[JCR상위 5.9] OUTCOMES BY BASELINE LIVER FUNCTION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH TREMELIMUMAB AND DURVALUMAB IN THE PHASE 3 HIMALAYA STUDY | SCIE | 5.9 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Min, Ahreum (Min, AH) |
Gyeongsang Natl Univ, Res Inst Nat Sci, Core Facil Ctr Photochem & Nanomat, Dept Chem BK21 FOUR, Jinju 52828, South Korea |
|
|
[JCR상위 5.9] Unraveling the fundamentals of pulsed laser-assisted synthesis of nanomaterials in liquids: Applications in energy and the environment | SCIE | 5.9 | PHYSICS, APPLIED | mychoi@gnu.ac.kr; | ||
|
Morozov, Viacheslav (Morozov, V) |
Hepatolog, Samara, Russia |
|
|
[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF) | SCIE | 5.9 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Nguyen, Anh-Hoa (Nguyen, AH) |
Gilead Sci Inc, Foster City, CA USA Gilead Sci Inc, Biostat, Foster City, CA USA |
|
|
[JCR상위 5.9] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF) [JCR상위 3.8] Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B |
SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | frida.abramov@gilead.com; |
페이지 이동: